STAAR Surgical shareholders have voted to reject Alcon’s revised acquisition offer after a contentious proxy battle. The maker of implantable lenses for the eye intends to terminate its merger agreement with Alcon, STAAR said, based on the preliminary results from a special shareholder meeting. Final results from the meeting will be reported in a regulatory filing. Neither company will pay a termination fee. STAAR said it would remain a stand-alone, publicly traded company. Its shares fell more than 12%, to trade at $20.92, Tuesday morning on the Nasdaq.
Read the full article: STAAR Shareholders Reject Alcon’s Revised Buyout Offer //
Source: https://www.medtechdive.com/news/STAAR-Surgical-shareholders-vote-Alcon-acquisition/808865/